Serum Institute of India Overview
- Year Founded
-
1966
- Status
-
Private
- Employees
-
4,176
- Latest Deal Type
-
Corporate
- Financing Rounds
-
5
- Investments
-
19
Serum Institute of India General Information
Description
Developer and manufacturer of vaccines and immuno-biologicals intended to offer life-saving drugs at prices affordable to the common man. The company specializes in making life-saving biologicals that include Tetanus Toxoid, Diphtheria, Measles, Mumps, and Covid-19 vaccines, among others, using modern genetic and cell-based technologies, thereby helping patients to get treated for the diseases through national immunization programs.
Contact Information
Website
www.seruminstitute.comCorporate Office
- 212/2, Hadapsar, Off Soli Poonawalla Road
- Pune, Maharashtra 411028
- India
Corporate Office
- 212/2, Hadapsar, Off Soli Poonawalla Road
- Pune, Maharashtra 411028
- India
Serum Institute of India Timeline
Serum Institute of India Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Serum Institute of India Comparisons
Industry
Financing
Details
Serum Institute of India Competitors (5)
One of Serum Institute of India’s 5 competitors is Biological E, a Venture Capital-Backed company based in Hyderabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biological E | Venture Capital-Backed | Hyderabad, India | ||||
| Bharat Biotech | Formerly PE-Backed | Hyderabad, India | ||||
| Bharat Serums and Vaccines | Formerly PE-Backed | Navi Mumbai, India | ||||
| Premas Biotech | Venture Capital-Backed | Gurugram, India | ||||
| Biocon | Formerly PE-Backed | Bengaluru, India |
Serum Institute of India Patents
Serum Institute of India Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4763219-A1 | Recombinant mycobacterium as a vaccine in the prevention of tuberculosis occurrence and recurrence | Pending | 23-Dec-2024 | ||
| WO-2026139478-A1 | Recombinant mycobacterium as a vaccine in the prevention of tuberculosis occurrence and recurrence | Pending | 23-Dec-2024 | ||
| GB-202506555-D0 | Novel reference standard and improved method for quantification of saccharide in vaccine | Pending | 30-Apr-2024 | ||
| GB-2701058-A | Novel reference standard and improved method for quantification of saccharide in vaccine | Pending | 30-Apr-2024 | ||
| AU-2025202268-A1 | Saccharide coupled microsphere, methods of preparation & applications thereof | Pending | 04-Apr-2024 | G01N33/54313 |
Serum Institute of India Signals
Serum Institute of India Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Serum Institute of India Investments & Acquisitions (19)
Serum Institute of India’s most recent deal was a Corporate with Yotta Data Services for . The deal was made on 20-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Yotta Data Services | 20-Sep-2026 | Corporate | Systems and Information Management | ||
| JetSynthesys | 16-Apr-2025 | Later Stage VC | Entertainment Software | ||
| Hervolution Therapeutics | 19-Dec-2024 | Later Stage VC | Drug Discovery | ||
| Dharma Productions | 15-Nov-2024 | Merger/Acquisition | Movies, Music and Entertainment | ||
| IntegriMedical | 17-May-2024 | Corporate | Drug Delivery |
Serum Institute of India Exits (6)
Serum Institute of India’s most recent exit was on 25-Apr-2023 from Biocon Biologics. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Biocon Biologics | 25-Apr-2023 | Completed |
|
||
| Biocon Biologics | 18-May-2022 | Completed |
|
||
| PolicyBazaar | 14-Apr-2021 | Completed |
|
||
| X-Vax | 18-Jul-2019 | Completed |
|
||
| Visterra | 05-Oct-2017 | Later Stage VC | Completed |
|
Serum Institute of India Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Bilthoven Biologicals | Bilthoven, Netherlands | 2011 | |
| SCHOTT Poonawalla | Mumbai, India | 1990 | |
| Dharma Productions | Mumbai, India | 1976 |
Serum Institute of India FAQs
-
When was Serum Institute of India founded?
Serum Institute of India was founded in 1966.
-
Where is Serum Institute of India headquartered?
Serum Institute of India is headquartered in Pune, India.
-
What is the size of Serum Institute of India?
Serum Institute of India has 4,176 total employees.
-
What industry is Serum Institute of India in?
Serum Institute of India’s primary industry is Pharmaceuticals.
-
Is Serum Institute of India a private or public company?
Serum Institute of India is a Private company.
-
What is Serum Institute of India’s current revenue?
The current revenue for Serum Institute of India is .
-
Who are Serum Institute of India’s investors?
Gavi Alliance, Coalition for Epidemic Preparedness Innovations, Global Health Investment Corporation, and Gates Foundation have invested in Serum Institute of India.
-
Who are Serum Institute of India’s competitors?
Biological E, Bharat Biotech, Bharat Serums and Vaccines, Premas Biotech, and Biocon are competitors of Serum Institute of India.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process